Type 2 diabetes European Commission has granted marketing authorization in Europe. For Sanofi’s Suliqua, a once-daily injection for the treatment of adults with Type 2 diabetes. Suliqua is authorize for use in combination with metformin to improve glycemic control. When this has not read more »

Researchers in an international study have uncovered new genetic evidence of how the benefits of the world’s most commonly used Type 2 diabetes drug may vary between individuals. Metformin, the drug used by hundreds of millions of people with Type 2 diabetes read more »

In December AstraZeneca announced an agreement under which it will acquire the entirety of Bristol-Myers Squibb’s interests in the companies’ diabetes alliance for an initial consideration of $2.7 billion on completion and up to $1.4 billion in regulatory, launch and sales-related payments. read more »

A Chinese research study of diabetes patients with coronary heart disease concluded that metformin is more effective than glipizide in reducing the risk of major cardiovascular events, such as stroke and heart attack. Researchers at the Shanghai Jiao Tong University School of Medicine read more »

Eli Lilly & Co says its once-weekly injectible drug, dulaglutide, has outperformed three other widely taken drugs in three just-concluded Phase III studies. According to Lilly, dulaglutide, a GLP-1 analog, worked better to reduce HbA1c levels than metformin, Merck & Co.’s Januvia (sitagliptin), read more »

Metformin is the aspirin of the diabetes world, an almost-wonder drug that proves itself again and again the longer it’s around. This time, a new study shows that postmenopausal women with diabetes who have taken metformin for several years are 25 percent read more »

GPs are being urged to ramp up diabetes treatment within just three months if they do not reach their glycaemic goals on metformin alone, under a radical update of guidelines issued by European and American diabetes societies. The new approach would advise GPs read more »

According to new guidelines from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) it may be better for older people with type 2 diabetes to have less stringent HbA1c goals than younger type 2s, The recommendations, read more »

The latest clinical guidelines for treating type 2 diabetes from the American College of Physicians (ACP) indicate that when diet, exercise, and weight loss fail to control blood sugar levels in early type 2 patients, physicians should prescribe metformin as the first read more »

Many people with diabetes take more than one form of medication. Keeping tabs on your tablets can be a real headache! Pill containers can help. The Medidos pill container has seven clearly marked boxes for each day of the week. Each box read more »